专利号:WO-9312076-A1 优先权日:1991-12-13 标题:Reagents for automated synthesis of peptide analogs 发明人:WEBB THOMAS ROY 权利人:CORVAS INT INC 摘要:Reagents suitable for synthesis of peptide analogs using automated peptide synthesis and procedures for synthesis of peptide analogs are provided.
专利号:US-5367072-A 优先权日:1990-12-14 标 题 :Reagents for automated synthesis of peptide analogs 发明人:WEBB THOMAS R 权利人:CORVAS INT INC 摘要:Reagents suitable for synthesis of peptide analogs using automated peptide synthesis and procedures for synthesis of peptide analogs are provided.
专利号:US-4287123-A 优先权日:1980-01-14 标题 :Synthesis of thienamycin via (3SR, 4RS)-3-((RS)-1-acyloxyethyl)-2-oxo-4-azetidineacetate 发明人:LIU THOMAS M H; MELILLO DAVID G; RYAN KENNETH M; SHINKAI ICHIRO; SLETZINGER MEYER 权利人:MERCK & CO INC 摘要:Disclosed is a process for the stereocontrolled total synthesis of thienamycin, which synthesis proceeds via intermediate II: II wherein R is a readily removable carboxyl protecting group; and is a readily removable acyl group.
专利号:WO-2025078505-A1 优先权日:2023-10-13 标 题 :One pot gmp scalable production method for the synthesis of dextran-guanidine-bisphosphonate conjugate 发明人:HOLMBERG ANDERS R 权利人:DEXTECH MEDICAL AB 摘要:The disclosure relates to a large scale GMP synthesis of a modified dextran conjugate, and more particularly to a dextran-guanidine-bisphosphonate conjugate wherein the bisphosphonate is an alendronate group. The disclosure relates to a large scale GMP synthesis that produces high purity, pharmaceutical grade dextran-guanidine-bisphosphonate conjugate. The present disclosure further concerns the use of said dextran-guanidine-bisphosphonate conjugate in medicines treating tumors.
专利号:US-RE37813-E 优先权日:1996-02-21 标题 :Process for the synthesis of nabumetone 发明人:CANNATA VINCENZO; BERTONI AMILCARE; BIANCHI STEFANO 权利人:HONEYWELL INT INC 摘要:New process for the synthesis of the antiinflammatory drug known as nabumetone that consists in reacting 2-acetyl-5-bromo-6-methoxynaphthalene with an alkyl acetate in presence of an alkaline alcoholate to get 4-(5-bromo-6-methoxy-2-naphthyl)-4-hydroxybut-3-en-2-one that by catalytic hydrogenation in a polar solvent and in presence of a base gives 4-(6-methoxy-2-naphthyl)butan-2-one known as nabumetone.
专利号:WO-2025109557-A1 优先权日:2023-11-24 标题:Process for the synthesis of monoesters of ethylenediaminetetraacetic acid 发明人:TERAZONO YUICHI 权利人:NUTRIEN AG SOLUTIONS CANADA INC 摘要:A process for the synthesis of a compound of Formula (I) is provided. (I) wherein R is selected from the group consisting of alkyl, alkenyl, alkynyl, and steroidyl. The process comprises reacting a compound of Formula (IIa), Formula (IIb) or a mixture thereof with a compound of Formula R-X, to obtain a compound of Formula (IIIa), a compound of Formula (IIIb) or a mixture thereof, wherein A+ is a cesium cation, a quaternary ammonium cation or a quaternary phosphonium cation, and X is a leaving group; and reacting the compound of Formula (IIIa), compound of Formula (IIIb) or mixture thereof with an acid to obtain a reaction product which comprises the compound of Formula (I). (IIa) (IIb) (IIIa) (IIIb)
[参考文献]: Andrew D Shaw, Et Al. Major Complications, Mortality, And Resource Utilization After Open Abdominal Surgery: 0.9% Saline Compared To Plasma-Lyte. Ann Surg. 2012 May;255(5):821-9. [参考文献]: Dileep N Lobo, Et Al. Intravenous 0.9% Saline And General Surgical Patients: A Problem, Not A Solution. Ann Surg. 2012 May;255(5):830-2. [参考文献]: Dinesh Koju, Et Al. Effect Of Different Biosynthetic Precursors On The Production Of Nargenicin A1 From Metabolically Engineered Nocardia Sp. Cs682. J Microbiol Biotechnol. 2012 Aug;22(8):1127-32. [参考文献]: Jeong Heo Kwon, Et Al. Feasibility Of A Facile Butanol Bioproduction Using Planetary Mill Pretreatment. Bioresour Technol. 2016 Jan:199:283-287. [参考文献]: Nilesh Jain, Et Al. Novel Uv-Spectrophotometric Method For Quantitative Estimation Of Furazolidone Using Mixed Hydrotropic Agent. Pak J Pharm Sci. 2013 Jan;26(1):159-62.
合成参考文献
参考文献:10.1007/s10895-011-0917-0 摘要:Shah J, Jan MR, Shah S, Naeem M. Spectrofluorimetric protocol for ceftriaxone in commercial formulation and human plasma after condensation with formaldehyde and ethyl acetoacetate. J Fluoresc. 2011 Nov;21(6):2155–63. doi: 10.1007/s10895-011-0917-0.